Identification and characterisation of multiple linear B cell protectopes in the respiratory syncytial virus G protein

Vaccine

Volumn 19, Issue 17-19, 2001, Pages 2345-2351

  Power, Ultan F ^a   Plotnicky Gilquin, Hélène ^a   Goetsch, Liliane ^a   Champion, Thierry ^a   Beck, Alain ^a   Haeuw, Jean François ^a   Nguyen, Thien Ngoc ^a   Bonnefoy, Jean Yves ^a   Corvaïa, Nathalie ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

BBG2Na; Protectopes; RSV

Indexed keywords

CHIMERIC PROTEIN; EPITOPE; LIVE VACCINE; MONOCLONAL ANTIBODY; PROTEIN BBG2NA; PROTEIN G; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY; RESPIRATORY SYNCYTIAL VIRUS VACCINE; UNCLASSIFIED DRUG;

ACTIVE IMMUNIZATION; ANALYTIC METHOD; B LYMPHOCYTE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG IDENTIFICATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PEPTIDE MAPPING; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VACCINATION; VIRUS INFECTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; B-LYMPHOCYTES; EPITOPE MAPPING; EPITOPES; HUMANS; IMMUNIZATION, PASSIVE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; RESPIRATORY SYNCYTIAL VIRUSES; VACCINES, SUBUNIT; VIRAL PROTEINS; VIRAL VACCINES;

EID: 0035925632     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00525-9     Document Type: Conference Paper

References (35)

1. Respiratory syncytial virus
2. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults
3. Viral respiratory infections in the institutionalized elderly: Clinical and epidemiologic findings
4. Respiratory syncytial virus and influenza A infections in the hospitalized elderly
5. Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults
6. Severe respiratory syncytial virus pneumonia after autologous bone marrow transplantation: A report of three cases and review
7. Respiratory syncytial virus infection in the elderly
8. Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: Evaluation of the contributions of F and G glycoproteins to immunity
9. The respiratory syncytial virus subgroup B attachment glycoprotein: Analysis of sequence, expression from a recombinant vector, and evaluation as an immunogen against homologous and heterologous subgroup virus challenge
10. Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment
11. Protective immunity against respiratory syncytial virus in early life after murine maternal or neonatal vaccination with the recombinant G fusion protein BBG2Na
12. Protective efficacy against respiratory syncytial virus following murine neonatal immunization with BBG2Na vaccine: Influence of adjuvants and maternal antibodies
13. Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein
14. Immunization with a peptide derived from the G glycoprotein of bovine respiratory syncytial virus (BRSV) reduces the incidence of BRSV-associated pneumonia in the natural host
15. Protection of BALB/c mice from respiratory syncytial virus infection by immunization with a synthetic peptide derived from the G glycoprotein
16. Monoclonal antibody neutralization escape mutants of respiratory syncytial virus with unique alterations in the attachment (G) protein
17. Site-directed serology with synthetic peptides representing the large glycoprotein G of respiratory syncytial virus
18. Challenge of BALB/c mice with respiratory syncytial virus does not enhance the Th2 pathway induced after immunization with a recombinant G fusion protein, BBG2Na, in aluminum hydroxide
19. The recombinant Klebsiella pneumoniae outer membrane protein OmpA has carrier properties for conjugated antigenic peptides
20. Hydrophobicity engineering to increase solubility and stability of a recombinant protein from respiratory syncytial virus
21. Chromosomal sequencing using a PCR-based biotin-capture method allowed isolation of the complete gene for the outer membrane protein A of Klebsiella pneumoniae
22. Analysis and use of the serum albumin binding domains of streptococcal protein G
23. Identification of multiple protective epitopes (Protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein
24. Absence of lung immunopathology following respiratory syncytial virus (RSV) challenge of BALB/c mice immunized with BBG2Na, a recombinant RSV vaccine candidate
25. Dose response and effect of route of administration on the immunogenicity and protective efficacy of BBG2Na, a recombinant respiratory syncytial virus vaccine candidate
26. CD4+ T-cell-mediated anti-viral protection of upper respiratory tract in BALB/c mice following parenteral immunization with a recombinant Respiratory syncytial virus G protein fragment
27. Evolutionary pattern of human respiratory syncytial virus (subgroup A): Cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein
28. Identification of variable domains of the attachment (G) protein of subgroup A respiratory syncytial viruses
29. Genetic diversity of the attachment protein of subgroup B respiratory syncytial viruses
30. Analysis of relatedness of subgroup A respiratory syncytial viruses isolated worldwide
31. Location of the epitope recognized by monoclonal antibody 63G on the primary structure of human respiratory syncytial virus G glycoprotein and the ability of synthetic peptides containing this epitope to induce neutralizing antibodies
32. Monoclonal antibodies protect against respiratory syncytial virus infection in mice
33. Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants
34. Host responses to respiratory virus infection and immunization, Curr. Top. Microbiol